Summary & Overview
HCPCS G6043: Barbiturates, Not Elsewhere Specified
HCPCS Level II code G6043 designates barbiturate medications categorized as “not elsewhere specified.” This code matters nationally because barbiturates remain controlled substances with specific clinical uses, and accurate coding ensures appropriate coverage determinations, medical record clarity, and regulatory compliance. Payors commonly involved include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical and billing context for G6043, including how the code is used to represent provision or administration of barbiturate drugs that lack a more specific HCPCS entry. The publication provides benchmarks and comparative coverage perspectives across major national payors, outlines common billing modifiers when applicable, and summarizes operational considerations for outpatient pharmacy and ambulatory administration settings. It also highlights policy and documentation priorities relevant to controlled substance dispensing and claims submission. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code G6043 represents Barbiturates, not elsewhere specified. This code denotes billing for barbiturate medications that are not classified under more specific HCPCS entries. The service type is medication administration and supply of a barbiturate agent for therapeutic use. The typical site of service is outpatient pharmacy dispensing or clinical administration in ambulatory and hospital outpatient settings.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient pharmacy or specialty infusion clinic for medication management involving barbiturate therapy. The medication represented by G6043 is a barbiturate formulation listed as “not elsewhere specified,” used in rare situations such as short-term treatment of severe refractory insomnia, selected seizure disorders when first-line agents are ineffective or contraindicated, or for pre-procedural sedation in specific settings. Clinical workflow begins with the prescribing clinician (neurologist, psychiatrist, or anesthesiologist) documenting diagnosis, indication, dosage, route, and duration. The prescription is processed by the pharmacy or the hospital’s outpatient medication administration service. If administered in a clinic or facility, documentation includes medication administration record, informed consent when applicable, monitoring of vital signs and level of consciousness, and billing using the G6043 HCPCS Level II code. Modifier TC may be appended when only the technical component of a compound or administration service is reported. Typical site of service is outpatient pharmacy dispensing, ambulatory infusion/medication clinic, or hospital outpatient department. Typical patient scenario: a 42-year-old with refractory focal seizures for whom multiple antiseizure medications have failed and a short course of an older barbiturate is prescribed under close monitoring in an outpatient infusion center; the pharmacy prepares the medication, the clinic documents administration and monitoring, and billing uses G6043 with applicable modifiers and the seizure-related ICD-10 diagnosis on the claim.
Coding Specifications
| Modifier |
|---|